hydralazine has been researched along with B16 Melanoma in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremner, JC | 1 |
| Counsell, CJ | 1 |
| Adams, GE | 1 |
| Stratford, IJ | 1 |
| Wood, PJ | 1 |
| Dunn, JF | 1 |
| Radda, GK | 1 |
1 other study available for hydralazine and B16 Melanoma
| Article | Year |
|---|---|
In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
Topics: Animals; Colonic Neoplasms; Humans; Hydralazine; Magnetic Resonance Spectroscopy; Melanoma, Experime | 1991 |